Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Obesity is a chronic condition, and stopping medication may lead to weight regain
Ryan Kent, FNP-BC is on site reviewing intakes, labs, and refills
It would also assist in further weight loss or reduction in other medications to reduce polypharmacy. Oral semaglutide is only currently approved for treating type 2 diabetes, with only two GLP-1-related injectables liraglutide and Wegovy approved for treating obesity
GLP-1s are great, but it looks like people cant stay on them forever, says James Hamilton, Arrowheads chief medical officer
US$ 20.54
US$ 25.27
US$ 24.01
US$ 23.44
US$ 26.09
